Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals
HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
Market Cap $15.63M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JAV | Ann: Eureka Mining Plans Advancing | 21/08/25 | 27 | 10K | |||
|
|||||||
JAV | Ann: Updated Eureka Mining Plan Delivers Grade and Ounce Increase | 07/08/25 | 9 | 2.7K | |||
|
|||||||
JAV | Ann: Updated MRE over Eureka Gold Project | 07/08/25 | 9 | 4.0K | |||
|
|||||||
JAV | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 30/07/25 | 0 | 387 | |||
|
|||||||
JAV | Ann: Change of Director's Interest Notice - BM | 07/07/25 | 0 | 360 | |||
|
|||||||
JAV | Ann: Cleansing Notice | 04/07/25 | 0 | 324 | |||
|
|||||||
JAV | Ann: Application for quotation of securities - JAV | 04/07/25 | 0 | 250 | |||
|
|||||||
JAV | Ann: Application for quotation of securities - JAV | 04/07/25 | 0 | 286 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |